What is the appropriate treatment for acute pericarditis in a patient with an allergy to nonsteroidal anti-inflammatory drugs (NSAIDs)?

Treatment for Acute Pericarditis with NSAID Allergy

In patients with acute pericarditis who have an NSAID allergy, low-dose corticosteroids (prednisone 0.2-0.5 mg/kg/day) combined with colchicine should be used as second-line therapy after excluding infectious causes. 1

Treatment Algorithm

Step 1: Exclude Infectious Causes

Before initiating corticosteroids, you must rule out bacterial and tuberculous pericarditis, as steroids can worsen these conditions and lead to serious complications 1. This is non-negotiable in the setting of NSAID contraindication.

Step 2: Initiate Corticosteroid Therapy

• Dose: Prednisone 0.2-0.5 mg/kg/day (low to moderate dose)
• Do NOT use high doses (≥1.0 mg/kg/day) as these increase recurrence risk and side effects 1
• Maintain initial dose until symptoms resolve AND C-reactive protein (CRP) normalizes 1

Step 3: Add Colchicine

• Weight-adjusted dosing:
  • 0.5 mg once daily if <70 kg
  • 0.5 mg twice daily if ≥70 kg
• Duration: Minimum 3 months 1
• Colchicine is essential even with corticosteroids to reduce recurrence risk from 37.5% to 16.7% 2

Step 4: Monitor Treatment Response

• Use CRP levels to guide treatment duration and assess response 1
• Continue therapy until symptoms resolve AND CRP normalizes
• Typical duration: 1-2 weeks for uncomplicated cases, but can be longer 1

Step 5: Tapering Strategy

Critical pitfall: Corticosteroid tapering must be extremely slow to prevent recurrence 1

• Begin tapering only after complete symptom resolution and CRP normalization
• Danger zone: 10-15 mg/day prednisone threshold 1
• At this threshold, decrease by only 1.0-2.5 mg every 2-6 weeks 1
• If recurrence occurs during taper, do NOT increase corticosteroid dose; instead maximize other supportive measures and add analgesics 1

Step 6: Exercise Restriction

• Non-athletes: Restrict activity until symptom resolution and CRP normalization 1
• Athletes: Minimum 3 months restriction until symptoms resolve AND CRP, ECG, and echocardiogram normalize 1

Important Caveats

Why Corticosteroids Are Second-Line

The 2015 ESC Guidelines explicitly state corticosteroids are not recommended as first-line therapy (Class III recommendation) 1. This is because they:

• Favor chronic disease evolution
• Promote drug dependence
• Increase recurrence rates to 50% in some cases 1

However, when NSAIDs are contraindicated due to true allergy, corticosteroids become the appropriate choice 1.

Specific Indications Where Corticosteroids Are More Acceptable

Corticosteroids are more appropriate (and safer) when pericarditis occurs with:

• Autoimmune/systemic inflammatory diseases
• Post-pericardiotomy syndrome
• Pregnancy beyond 20 weeks 1

If Treatment Fails

For corticosteroid-dependent or refractory cases not responding to colchicine:

1. Third-line: Consider IV immunoglobulin, anakinra (IL-1 antagonist), or azathioprine 1
2. Fourth-line: Pericardiectomy only after exhaustive medical therapy at specialized centers 1

Key Monitoring Parameters

• Serial CRP measurements to guide therapy duration
• Echocardiography to monitor for effusion/tamponade
• ECG changes
• Symptoms (chest pain resolution)

Bottom line: The combination of low-dose corticosteroids plus colchicine provides effective treatment when NSAIDs cannot be used, but requires meticulous attention to infectious exclusion, slow tapering, and CRP-guided management to minimize the well-documented risks of corticosteroid therapy in pericarditis.